Global Epidermolysis Bullosa Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 109
Inquire Before Buying

Market Analysis and Insights: Global Epidermolysis Bullosa Therapeutics Market

The global Epidermolysis Bullosa Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epidermolysis Bullosa Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epidermolysis Bullosa Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epidermolysis Bullosa Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epidermolysis Bullosa Therapeutics market.

Global Epidermolysis Bullosa Therapeutics Scope and Market Size

Epidermolysis Bullosa Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epidermolysis Bullosa Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- EB-201

- FCX-007

- ICX-RHY

- INM-750

- Others

Segment by Application

- Clinic

- Hospital

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Birken AG

- Fibrocell Science, Inc.

- GlaxoSmithKline Plc

- InMed Pharmaceuticals Inc.

- Karus Therapeutics Limited

- ProQR Therapeutics N.V.

- RegeneRx Biopharmaceuticals, Inc.

- Scioderm, Inc.

- Stratatech Corporation

- TWi Pharmaceuticals, Inc.

- WAVE Life Sciences Ltd.

Global Epidermolysis Bullosa Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epidermolysis Bullosa Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 EB-201
1.2.3 FCX-007
1.2.4 ICX-RHY
1.2.5 INM-750
1.2.6 Others
1.3 Market by Application
1.3.1 Global Epidermolysis Bullosa Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Epidermolysis Bullosa Therapeutics Market Perspective (2016-2027)
2.2 Epidermolysis Bullosa Therapeutics Growth Trends by Regions
2.2.1 Epidermolysis Bullosa Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epidermolysis Bullosa Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Epidermolysis Bullosa Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Epidermolysis Bullosa Therapeutics Industry Dynamic
2.3.1 Epidermolysis Bullosa Therapeutics Market Trends
2.3.2 Epidermolysis Bullosa Therapeutics Market Drivers
2.3.3 Epidermolysis Bullosa Therapeutics Market Challenges
2.3.4 Epidermolysis Bullosa Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epidermolysis Bullosa Therapeutics Players by Revenue
3.1.1 Global Top Epidermolysis Bullosa Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Epidermolysis Bullosa Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epidermolysis Bullosa Therapeutics Revenue
3.4 Global Epidermolysis Bullosa Therapeutics Market Concentration Ratio
3.4.1 Global Epidermolysis Bullosa Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epidermolysis Bullosa Therapeutics Revenue in 2020
3.5 Epidermolysis Bullosa Therapeutics Key Players Head office and Area Served
3.6 Key Players Epidermolysis Bullosa Therapeutics Product Solution and Service
3.7 Date of Enter into Epidermolysis Bullosa Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epidermolysis Bullosa Therapeutics Breakdown Data by Type
4.1 Global Epidermolysis Bullosa Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Epidermolysis Bullosa Therapeutics Forecasted Market Size by Type (2022-2027)
5 Epidermolysis Bullosa Therapeutics Breakdown Data by Application
5.1 Global Epidermolysis Bullosa Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Epidermolysis Bullosa Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Epidermolysis Bullosa Therapeutics Market Size (2016-2027)
6.2 North America Epidermolysis Bullosa Therapeutics Market Size by Type
6.2.1 North America Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2027)
6.3 North America Epidermolysis Bullosa Therapeutics Market Size by Application
6.3.1 North America Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2027)
6.4 North America Epidermolysis Bullosa Therapeutics Market Size by Country
6.4.1 North America Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Epidermolysis Bullosa Therapeutics Market Size (2016-2027)
7.2 Europe Epidermolysis Bullosa Therapeutics Market Size by Type
7.2.1 Europe Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2027)
7.3 Europe Epidermolysis Bullosa Therapeutics Market Size by Application
7.3.1 Europe Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2027)
7.4 Europe Epidermolysis Bullosa Therapeutics Market Size by Country
7.4.1 Europe Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Type
8.2.1 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Application
8.3.1 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Region
8.4.1 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Epidermolysis Bullosa Therapeutics Market Size (2016-2027)
9.2 Latin America Epidermolysis Bullosa Therapeutics Market Size by Type
9.2.1 Latin America Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Epidermolysis Bullosa Therapeutics Market Size by Application
9.3.1 Latin America Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Epidermolysis Bullosa Therapeutics Market Size by Country
9.4.1 Latin America Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Type
10.2.1 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Application
10.3.1 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Country
10.4.1 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Birken AG
11.1.1 Birken AG Company Details
11.1.2 Birken AG Business Overview
11.1.3 Birken AG Epidermolysis Bullosa Therapeutics Introduction
11.1.4 Birken AG Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.1.5 Birken AG Recent Development
11.2 Fibrocell Science, Inc.
11.2.1 Fibrocell Science, Inc. Company Details
11.2.2 Fibrocell Science, Inc. Business Overview
11.2.3 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Introduction
11.2.4 Fibrocell Science, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.2.5 Fibrocell Science, Inc. Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 InMed Pharmaceuticals Inc.
11.4.1 InMed Pharmaceuticals Inc. Company Details
11.4.2 InMed Pharmaceuticals Inc. Business Overview
11.4.3 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Introduction
11.4.4 InMed Pharmaceuticals Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.4.5 InMed Pharmaceuticals Inc. Recent Development
11.5 Karus Therapeutics Limited
11.5.1 Karus Therapeutics Limited Company Details
11.5.2 Karus Therapeutics Limited Business Overview
11.5.3 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Introduction
11.5.4 Karus Therapeutics Limited Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.5.5 Karus Therapeutics Limited Recent Development
11.6 ProQR Therapeutics N.V.
11.6.1 ProQR Therapeutics N.V. Company Details
11.6.2 ProQR Therapeutics N.V. Business Overview
11.6.3 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Introduction
11.6.4 ProQR Therapeutics N.V. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.6.5 ProQR Therapeutics N.V. Recent Development
11.7 RegeneRx Biopharmaceuticals, Inc.
11.7.1 RegeneRx Biopharmaceuticals, Inc. Company Details
11.7.2 RegeneRx Biopharmaceuticals, Inc. Business Overview
11.7.3 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Introduction
11.7.4 RegeneRx Biopharmaceuticals, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.7.5 RegeneRx Biopharmaceuticals, Inc. Recent Development
11.8 Scioderm, Inc.
11.8.1 Scioderm, Inc. Company Details
11.8.2 Scioderm, Inc. Business Overview
11.8.3 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Introduction
11.8.4 Scioderm, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.8.5 Scioderm, Inc. Recent Development
11.9 Stratatech Corporation
11.9.1 Stratatech Corporation Company Details
11.9.2 Stratatech Corporation Business Overview
11.9.3 Stratatech Corporation Epidermolysis Bullosa Therapeutics Introduction
11.9.4 Stratatech Corporation Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.9.5 Stratatech Corporation Recent Development
11.10 TWi Pharmaceuticals, Inc.
11.10.1 TWi Pharmaceuticals, Inc. Company Details
11.10.2 TWi Pharmaceuticals, Inc. Business Overview
11.10.3 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Introduction
11.10.4 TWi Pharmaceuticals, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.10.5 TWi Pharmaceuticals, Inc. Recent Development
11.11 WAVE Life Sciences Ltd.
11.11.1 WAVE Life Sciences Ltd. Company Details
11.11.2 WAVE Life Sciences Ltd. Business Overview
11.11.3 WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Introduction
11.11.4 WAVE Life Sciences Ltd. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021)
11.11.5 WAVE Life Sciences Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Epidermolysis Bullosa Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of EB-201
Table 3. Key Players of FCX-007
Table 4. Key Players of ICX-RHY
Table 5. Key Players of INM-750
Table 6. Key Players of Others
Table 7. Global Epidermolysis Bullosa Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Epidermolysis Bullosa Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Epidermolysis Bullosa Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Epidermolysis Bullosa Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Epidermolysis Bullosa Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Epidermolysis Bullosa Therapeutics Market Share by Regions (2022-2027)
Table 13. Epidermolysis Bullosa Therapeutics Market Trends
Table 14. Epidermolysis Bullosa Therapeutics Market Drivers
Table 15. Epidermolysis Bullosa Therapeutics Market Challenges
Table 16. Epidermolysis Bullosa Therapeutics Market Restraints
Table 17. Global Epidermolysis Bullosa Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Epidermolysis Bullosa Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Epidermolysis Bullosa Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermolysis Bullosa Therapeutics as of 2020)
Table 20. Ranking of Global Top Epidermolysis Bullosa Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Epidermolysis Bullosa Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Epidermolysis Bullosa Therapeutics Product Solution and Service
Table 24. Date of Enter into Epidermolysis Bullosa Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Epidermolysis Bullosa Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Epidermolysis Bullosa Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Epidermolysis Bullosa Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Birken AG Company Details
Table 65. Birken AG Business Overview
Table 66. Birken AG Epidermolysis Bullosa Therapeutics Product
Table 67. Birken AG Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Birken AG Recent Development
Table 69. Fibrocell Science, Inc. Company Details
Table 70. Fibrocell Science, Inc. Business Overview
Table 71. Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Product
Table 72. Fibrocell Science, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Fibrocell Science, Inc. Recent Development
Table 74. GlaxoSmithKline Plc Company Details
Table 75. GlaxoSmithKline Plc Business Overview
Table 76. GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Product
Table 77. GlaxoSmithKline Plc Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 78. GlaxoSmithKline Plc Recent Development
Table 79. InMed Pharmaceuticals Inc. Company Details
Table 80. InMed Pharmaceuticals Inc. Business Overview
Table 81. InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Product
Table 82. InMed Pharmaceuticals Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 83. InMed Pharmaceuticals Inc. Recent Development
Table 84. Karus Therapeutics Limited Company Details
Table 85. Karus Therapeutics Limited Business Overview
Table 86. Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Product
Table 87. Karus Therapeutics Limited Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Karus Therapeutics Limited Recent Development
Table 89. ProQR Therapeutics N.V. Company Details
Table 90. ProQR Therapeutics N.V. Business Overview
Table 91. ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Product
Table 92. ProQR Therapeutics N.V. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 93. ProQR Therapeutics N.V. Recent Development
Table 94. RegeneRx Biopharmaceuticals, Inc. Company Details
Table 95. RegeneRx Biopharmaceuticals, Inc. Business Overview
Table 96. RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Product
Table 97. RegeneRx Biopharmaceuticals, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 98. RegeneRx Biopharmaceuticals, Inc. Recent Development
Table 99. Scioderm, Inc. Company Details
Table 100. Scioderm, Inc. Business Overview
Table 101. Scioderm, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Scioderm, Inc. Recent Development
Table 103. Stratatech Corporation Company Details
Table 104. Stratatech Corporation Business Overview
Table 105. Stratatech Corporation Epidermolysis Bullosa Therapeutics Product
Table 106. Stratatech Corporation Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Stratatech Corporation Recent Development
Table 108. TWi Pharmaceuticals, Inc. Company Details
Table 109. TWi Pharmaceuticals, Inc. Business Overview
Table 110. TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Product
Table 111. TWi Pharmaceuticals, Inc. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 112. TWi Pharmaceuticals, Inc. Recent Development
Table 113. WAVE Life Sciences Ltd. Company Details
Table 114. WAVE Life Sciences Ltd. Business Overview
Table 115. WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Product
Table 116. WAVE Life Sciences Ltd. Revenue in Epidermolysis Bullosa Therapeutics Business (2016-2021) & (US$ Million)
Table 117. WAVE Life Sciences Ltd. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epidermolysis Bullosa Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. EB-201 Features
Figure 3. FCX-007 Features
Figure 4. ICX-RHY Features
Figure 5. INM-750 Features
Figure 6. Others Features
Figure 7. Global Epidermolysis Bullosa Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Epidermolysis Bullosa Therapeutics Report Years Considered
Figure 12. Global Epidermolysis Bullosa Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Epidermolysis Bullosa Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Epidermolysis Bullosa Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Epidermolysis Bullosa Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Epidermolysis Bullosa Therapeutics Market Share by Players in 2020
Figure 17. Global Top Epidermolysis Bullosa Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermolysis Bullosa Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Epidermolysis Bullosa Therapeutics Revenue in 2020
Figure 19. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Epidermolysis Bullosa Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Epidermolysis Bullosa Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Epidermolysis Bullosa Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Epidermolysis Bullosa Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Epidermolysis Bullosa Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Epidermolysis Bullosa Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Epidermolysis Bullosa Therapeutics Market Share by Region (2016-2027)
Figure 41. China Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Epidermolysis Bullosa Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Epidermolysis Bullosa Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Epidermolysis Bullosa Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Epidermolysis Bullosa Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Epidermolysis Bullosa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Birken AG Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 61. Fibrocell Science, Inc. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline Plc Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 63. InMed Pharmaceuticals Inc. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 64. Karus Therapeutics Limited Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 65. ProQR Therapeutics N.V. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 66. RegeneRx Biopharmaceuticals, Inc. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 67. Scioderm, Inc. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 68. Stratatech Corporation Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 69. TWi Pharmaceuticals, Inc. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 70. WAVE Life Sciences Ltd. Revenue Growth Rate in Epidermolysis Bullosa Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • 2021-2027 Global and Regional Flexible Endoscopes Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Jul-2021        Price: US 3500 Onwards        Pages: 177
    The global Flexible Endoscopes market was valued at 2552.86 Million USD in 2020 and will grow with a CAGR of 9.03% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Eur......
  • 2021-2027 Global and Regional Spinal Cord Stimulation (SCS) Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Jul-2021        Price: US 3500 Onwards        Pages: 144
    The global Spinal Cord Stimulation (SCS) Devices market was valued at 2268.23 Million USD in 2020 and will grow with a CAGR of 6.36% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North Ameri......
  • Global Disposable Blood Lancet Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 145
    Market Analysis and Insights: Global Disposable Blood Lancet Market The global Disposable Blood Lancet market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Disposable Blood Lancet Scope and Market Size The global Disposable Blood Lancet market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Disposable B......
  • Global Medical Uroflowmeter Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 148
    Uroflowmetry is a diagnostic test that is administered to check for abnormalities in the amount or flow rate of a patient's urine. The procedure is straightforward and painless, and simply involves urinating into a funnel device attached to an electronic meter. Doctors commonly use uroflowmetry to check for possible bladder obstructions, kidney problems, prostate enlargement, and urinary tract infections. Unusual test results indicate the need for additional testing procedures, such as x-rays an......
  • Global CO2 Laser Scalpel Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 133
    Market Analysis and Insights: Global CO2 Laser Scalpel Market The global CO2 Laser Scalpel market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global CO2 Laser Scalpel Scope and Market Size The global CO2 Laser Scalpel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CO2 Laser Scalpel market will be abl......
  • Global Surgical Laser Scalpel Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 144
    Market Analysis and Insights: Global Surgical Laser Scalpel Market The global Surgical Laser Scalpel market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Surgical Laser Scalpel Scope and Market Size The global Surgical Laser Scalpel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Laser S......
  • Global Automatic Hematocrit Centrifuges Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 134
    Hematocrit centrifuge is used for determination of volume fractions of erythrocytes (red blood cells) in blood and also for separation of micro blood and solutions. Market Analysis and Insights: Global Automatic Hematocrit Centrifuges Market The global Automatic Hematocrit Centrifuges market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Automatic Hematocrit Centrifuges Scope an......
  • Global Medical Disinfection Robot Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 143
    Medical disinfection robot has the capability to disinfect a whole room in mere minutes, generally using pulsed ultraviolet light. Market Analysis and Insights: Global Medical Disinfection Robot Market The global Medical Disinfection Robot market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Medical Disinfection Robot Scope and Market Size The global Medical Disinfection......
  • Global Disposable Medical Cotton Swabs Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 138
    Cotton swabs or cotton buds consist of one or two small wads of cotton wrapped around one or both ends of a short rod made of wood, rolled paper or plastic. Market Analysis and Insights: Global Disposable Medical Cotton Swabs Market The global Disposable Medical Cotton Swabs market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Disposable Medical Cotton Swabs Scope and Market Si......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected]esearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs